Intra-Cellular Therapies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Intra-Cellular Therapies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 86% to $464,370,000. The net income raised on -$139,674,000 and profit margin reached -30%. Total operating expenses were $590,006,000.
Profit Margin
| 2014 | 577.30K | -30.69M | -5316.37% |
|---|---|---|---|
| 2015 | 91.36K | -104.79M | -114698.5% |
| 2016 | 330.70K | -116.42M | -35205.79% |
| 2017 | 245.83K | -97.77M | -39771.64% |
| 2018 | 0 | -155.12M | |
| 2019 | 60.61K | -147.72M | -243713.69% |
| 2020 | 22.53M | -227.00M | -1007.54% |
| 2021 | 81.70M | -284.12M | -347.73% |
| 2022 | 249.13M | -256.25M | -102.86% |
| 2023 | 464.37M | -139.67M | -30.08% |
ITCI Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 464.37M | 249.13M | 81.70M | 22.53M | 60.61K | 0 | 245.83K | 330.70K | 91.36K | 577.30K |
Cost of revenue | 33.74M | 20.44M | 8.03M | 1.89M | 477.12K | 0 | 79.41M | 0 | 139.62K | 21.22M |
Gross profit | 430.62M | 228.68M | 73.67M | 20.63M | -416.50K | 0 | -79.17M | 330.70K | -48.26K | -20.64M |
Operating exp. | ||||||||||
Research and development | 180.14M | 134.71M | 88.84M | 65.78M | 89.12M | 132.16M | 79.41M | 93.83M | 87.71M | 21.22M |
Selling and marketing | 92.2M | 85.8M | 82.5M | 36.3M | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 590.00M | 492.31M | 359.36M | 251.86M | 154.07M | 162.26M | 103.08M | 118.58M | 105.90M | 31.56M |
Operating income | -159.38M | -263.62M | -285.68M | -231.22M | -154.01M | -162.26M | -102.84M | -118.25M | -105.81M | -30.98M |
Other income (expenses), net | 20.34M | 7.37M | 1.56M | 4.23M | 6.29M | 7.14M | 4.00M | 2.89M | 1.02M | 296.86K |
Income before tax | -139.03M | -256.25M | -284.12M | -226.99M | -147.72M | -155.12M | -98.83M | -115.36M | -104.79M | -30.68M |
Income tax expense | 636K | 6K | 5.63K | 13.51K | 1.6K | 1.6K | -1.06M | 1.06M | 1.6K | 1.6K |
Net income | -139.67M | -256.25M | -284.12M | -227.00M | -147.72M | -155.12M | -97.77M | -116.42M | -104.79M | -30.69M |
Earnings per share | ||||||||||
Basic EPS | -1.46 | -2.72 | -3.5 | -3.23 | -2.68 | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
Diluted EPS | -1.46 | -2.72 | -3.5 | -3.23 | -2.68 | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |